ERBB2 and breast cancer: On the molecular level, breast cancer is a heterogeneous disease with diverse genetic and epigenetic alterations, including activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), activation of hormone receptors (estrogen receptor and progesterone receptor), TP53 mutations, and BRCA mutations [3].